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072 The Journal of Thoracic and Cardbjective: Surgical repair of multiple muscular ventricular septal defects (Swiss cheese
eptum) is associated with important morbidity and mortality. We sought to examine
actors associated with permanent heart block, early mortality, and time-related sur-
ival. Additionally, we evaluated a new approach, transatrial re-endocardialization
f interventricular septum, to mitigate risk.
ethods: One hundred sixteen patients underwent surgery for multiple muscular
entricular septal defects (1982-2005), of whom 64 (55%) had associated cardiac
nomalies. Twenty-seven consecutive patients (median age 0.54 years, range 15
ays-7.2 years) underwent transatrial re-endocardialization (2002-2005). Forty-four
ercent had Swiss cheese septum (4 defects). Multivariable regression analysis
etermined risk factors for pacemaker and survival.
esults: Operative mortality for the entire cohort was 9%. Risk factors for death
ere double-outlet right ventricle (odds ratio 44.7, P  .003), ventriculotomy (odds
atio 6.4, P  .03), and fewer multiple muscular ventricular septal defects repaired
odds ratio 4.7/defect, P  .04). Era mortalities differed: 16% for 1982 through
990, 13% for 1990 through 1998, and 0% for 1999 through 2005, P  .006).
ourteen patients (12%) required a pacemaker. Time-related survivals at 1 and
0 years were 90%  3% and 82%  5%. Risk factors for death were double-outlet
ight ventricle (hazard ratio 8.3, P  .02) and longer bypass (hazard ratio 1.02/min,
 .02). In 27 re-endocardialization patients, a combined closure strategy to close
84 defects were applied: transatrial re-endocardialization (median 5, range 2-21),
atch (median 1, range 0-4), and device (range 0-1). Post-repair ventricular function
as good in 25 of 27 patients. The median number of residual defects was 1.5 (range
-3), and median residual jet width on color Doppler was 2.3 mm (range 0-4.2 mm).
ne child required a pacemaker. There were no early or late deaths.
onclusions: Outcome of surgical repair of multiple muscular ventricular septal defects
Swiss cheese septum) has improved. Transatrial re-endocardialization strategy enables
arly complete or nearly complete obliteration of multiple muscular ventricular septal
efects with minimal residual lesions (shunt, ventricular dysfunction). Long cardio-
ulmonary bypass duration is well tolerated. The incidence of permanent heart
lock has improved. Early echocardiographic and clinical outcomes are promising.
urgical treatment of children with multiple muscular ventricular septal defects
(mMVSDs) remains a challenge. It is associated with significant operative
mortality and complications, including ventricular dysfunction and complete
eart block.1-7 These lesions occur in isolation but also often exist in combin
ith other congenital cardiac lesions, such as transposition of the great arteries,
ouble-outlet right ventricle, and coarctation of the aorta, further complicating the
anagement of these children.1-7
iovascular Surgery ● November 2006
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DOptimal management of mMVSDs remains controver-
ial. Several techniques have been described, including ini-
ial pulmonary artery banding,4,6 single-stage repair with 
ransatrial or a transventricular approach,1-4,6-8 interven-
ional transcatheter device closure,9 and a hybrid strateg
ith intraoperative patch or perventricular device closure
echniques.5,10-14 Although different groups have achiev
uccessful results with all these strategies, each technique is
ssociated with important limitations.
In the last 4 years, we adopted a new treatment strategy:
ransatrial re-endocardialization (TAR). It is based on the
oncept that there are a finite number of trabeculations that
an be primarily approximated for defect closure. At com-
letion, the right ventricular endocardial cavity is smooth.
eep suturing, which may be a cause of ventricular dys-
unction and heart block, is avoided.
In this study, we sought to examine surgical results in
nfants and children undergoing primary closure of mMVSDs
hrough 23 years at our institution, including those requiring
epair of associated lesions. We intended to define patient
nd procedural risk factors for early and late death, and for
he development of complete heart block. In addition, we
imed to evaluate the early results of the TAR strategy and
ssess its role in addressing the major problems associated
ith surgical closure of mMVSDs.
atients and Methods
pproval of this study was obtained from the research ethics board
t The Hospital for Sick Children. From July 1982 to September
005, a total of 133 children (18 years) with mMVSDs under-
ent surgical repair at our institution. The patients were identified
y the surgical database. Clinical, operative, and outcome data
ere abstracted from the medical records. Patients who had a
iagnosis of mMVSDs but did not undergo initial or subsequent
losure of the defects were excluded. The risk factors for the
emaining 116 patients were analyzed.
entricular Septal Defect Characteristics
muscular ventricular septal defect (MVSD) is defined as an
ntraventricular communication that has a rim consisting entirely
f muscle. We used the ventricular septal defect (VSD) classifi-
ation of Van Praagh and Kirklin.1,15 Posterior muscular defect
re located in the inlet area (infratricuspid or inlet septal) of the
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
DORV  double-outlet right ventricle
MVSD muscular ventricular septal defect
mMVSDsmultiple muscular ventricular septal
defects
TAR  transatrial re-endocardialization
VSD  ventricular septal defectuscular septum, anterior muscular defects are located anterior to c
The Journal of Thoraciche septal band of the septomarginal trabeculation, midtrabecular
efects are proximal to the moderator band, and apical defects are
elow the moderator band in the ventricular apex.
A variety of descriptions have been used to define the highly
eficient ventricular septum with uncountable number of muscular
efects (Swiss cheese septum). The recent congenital heart surgery
omenclature defines Swiss cheese septum as 4 or more MVS15
MVSDs in each patient were characterized by preoperative
chocardiographic imaging and intraoperative inspection. It has
een our experience, however, that echocardiography often under-
stimates the number of mMVSDs and that intraoperative explo-
ation frequently reveals more defects that are detected by probing
he interventricular septum with a blunt-tip instrument.
perative Technique of TAR Strategy
ardiopulmonary bypass (CPB) was established with mild hypo-
hermia (32°C-34°C) by standard aortic and bicaval venous can-
ulation. The left ventricle was decompressed by a vent placed
hrough the interatrial septum. Myocardial protection was ante-
rade cold blood cardioplegia. In patients with associated cardiac
bnormalities, the CPB technique was modified as necessary to
llow correction of additional anomalies. If arch reconstruction
as necessary, deep hypothermic circulatory arrest with profound
ypothermia (with regional cerebral perfusion) was used. Expo-
ure of the mMVSDs was done through a right atriotomy and
hrough the tricuspid valve leaflets. It was possible to expose most
f the mMVSDs, with the apical defects being the most difficult,
ollowed by the anterior defects. Anterior defect exposure was
ometimes facilitated by a transverse pulmonary arteriotomy. A
ew were identified from the left side through an atrial septal defect
nd the mitral valve. Identification of mMVSDs was done by
entle probing of trabeculations with a right angle clamp to delin-
ate a connection with the left ventricle. Certain maneuvers, such
s probing through a perimembranous VSD or through the inter-
trial septum, may be helpful to completely identify all mMVSDs.
ccasionally, division of minor trabeculae (1-2 mm in diameter)
as needed to delineate the edges of the defects or expose some
pical defects. No major trabeculae or moderator band division
as performed in any of the patients undergoing TAR. A ventric-
lotomy was not used to access defects unless it was required for
ther repair (eg, right ventricular–pulmonary arterial conduit).
Although real-time imaging on a beating heart is a useful tool
or intraoperative localization of isolated big MVSDs, mMVSDs
re notoriously difficult to identify before the initial repair. Initial
chocardiography may reveal significant jets through large defects;
nce major defects such as large MVSDs or perimembranous
SDs are closed, however, additional small or moderately sized
nterior and midtrabecular defects are unmasked and detected on
ostoperative echocardiography, thus necessitating the probing
trategy.
The TAR strategy used 6-0 or 7-0 polypropylene sutures with
BV1 or BV175 needle (Ethicon, Inc, Somerville, NJ). The septal
rabeculations were approximated in two layers of superficial,
ndocardial running sutures. Each suture was started at the distal
dge of a trabeculation and run in a double-layer, simple, contin-
ous fashion to the other end of the trabeculation, where they were
ied (Figure 1). It was sometimes possible to close multiple 
ulations with the same suture. The TAR sutures were placed in all
and Cardiovascular Surgery ● Volume 132, Number 5 1073
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Dour compartments of the muscular septum (midtrabecular n 
8/27, anterior n  15/27, apical n  13/27, and inlet/posterior
 8/27).
A combination of different techniques was used to achieve
omplete obliteration of the VSDs. Large MVSDs in the inlet/
osterior muscular septum were usually closed with a synthetic
acron polyester fabric patch. Similarly, large apical MVSDs,
specially those located just underneath the moderator band with a
oorly defined muscular rim, were considered suitable for device
losure. The technique of intraoperative device closure of MVSDs
as been previously described.5 Figures 2 and 3 illustrate examples
f our combined closure strategy to achieve complete obliteration
f the intraventricular communications through the septum.
Evaluation of repair was by intraoperative transesophageal
chocardiography. Patients with echocardiographic demonstration
f potential significant residual shunt (n  4/27) underwent intra-
perative assessment of the shunt fraction. Complete operative
ata for patients undergoing the TAR strategy are presented in
able 1.
chocardiography and Follow-up
reoperative echocardiographic reports were collected and re-
iewed. The numbers and locations of mMVSDs were gathered.
ostoperative echocardiograms for all patients undergoing TAR,
sually done before hospital discharge, were retrospectively re-
igure 1. Re-endocardialization strategy relies on double-layer
uturing of septal trabeculations to each other with fine, super-
cial, endocardial running sutures.
igure 2. A, Preoperative example of patient 1withmultiple ventricular
eptal defects, including perimembranous defect, andmultiplemuscular
efects involving posterior/inlet, midtrabecular, apical, and anterior
ompartments. B, Complete obliteration of ventricular septum
as achieved in patient 1 with patch repair of perimembranous
nd large inlet muscular defects, with re-endocardialization su-
ures to obliterate completely remaining defects. p
074 The Journal of Thoracic and Cardiovascular Surgery ● Noviewed by a single, blinded cardiologist (M.O.). The numbers and
ocations of residual shunts were reported. Additionally, the size of
ach residual defect was measured by color flow Doppler.
igure 3. A, Preoperative example of patient 2 with multiple
entricular septal defects, including perimembranous defect, and
ultiple muscular defects involving posterior/inlet, midtrabecu-
ar, apical, and anterior compartments. B, Complete obliteration
f ventricular septum was achieved in patient 2 with patch repair of
erimembranous defect, intraoperative device closure of large api-
al defect underneath moderator band, and re-endocardialization
utures to obliterate completely remaining defects.
ABLE 1. Operative data for 27 patients with multiple mus-
ular ventricular septal defects (mMVSDs) undergoing
ransatrial re-endocardialization (TAR)
o. of patients 27
o. of closed defects (median and range) 7 (3-22)
TAR 5 (2-21)
Patch 1 (0-4)
Device 1 (0-1)
ocations of TAR suture placement (No.)*
Midtrabecular 18
Anterior 15
Apical 13
Inlet/posterior 8
dditional procedures (No.)
Closure of perimembranous VSD† 7
Tricuspid valve repair 6
Aortic arch reconstruction/coarctation repair 5
Atrioventricular septal defect repair 3
Tetralogy of Fallot repair 3
Arterial switch 1
Unifocalization and RV-PA conduit 1
PB (min, mean  SD) 146 52
Isolated mMVSDs 126 50
With associated lesions 167 57
ortic cross clamp time (min, mean  SD) 112  38
Isolated mMVSDs 104 40
With associated lesions 122 34
SD, Ventricular septal defect; RV-PA conduit, right ventricular–pulmonary
rterial conduit. *Numbers indicate number of patients requiring TAR
uturing in each compartment and not the total number of TAR closure
utures. †Closure of mMVSDs associated with only perimembranous VSD
atch was still considered in the isolated mMVSDs group.
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DLate outcomes were determined from clinic records when
vailable or from written correspondence with patient physicians,
hich is continuously updated in our surgical database. Median
ollow-up time was 3.78 years (range 3 days-20.1 years).
For the TAR group, follow-up echocardiograms were per-
ormed at a median of 1 month (range 2 days-1.9 years) after
epair. For the non-TAR group, follow-up echocardiograms were
erformed at a median interval of 4.1 months (range 1 day-6.3
ears) after repair.
tatistical Analysis
ata are given as frequency, median with range, or mean  SD as
ppropriate, with the number of nonmissing values indicated. All
ata analyses were performed with SAS statistical software (ver-
ion 9.1; SAS Institute, Inc, Cary, NC).
Overall cohort analysis (n  116). Multivariable factors as-
ociated with the binary outcomes of pacemaker implantation and
perative mortality (defined as death within 30 days of operation
r at any time during the same hospital admission) were modeled
ith logistic regression. Multivariable factors associated with the
umber of residual VSDs after operation were modeled with linear
egression. Time-related overall mortality after repair was initially
valuated with the Kaplan-Meier method, with risk-unadjusted
omparisons between stratified groups investigated with the
ehan-Wilcoxon statistic because most events occurred early.
isk factors for time-related mortality were then sought with
ultivariable Cox proportional hazard models, and risk-adjusted
urvival was compared between groups. Variables were pre-
creened to prevent model overdetermination, with only those
actors associated with more than five events used in the multiva-
iable model. Multicollinearity among variables within linear re-
ression models among variables was avoided by verifying that the
ariance inflation factor remained less than 2 for the full models.
ariable transforms were applied to improve calibration with the
isk scale, and interactions were tested among significant main
ffect terms in the full model. Score selection was used to select
he best three candidate models, followed by a stepwise selection
lgorithm with an entry criterion of P  .15.
Propensity-adjusted comparison with contemporaneous pa-
ients (n  56). Because patients undergoing TAR (n  27) were
ar fewer and not contemporaneous with those undergoing other
urgical repairs (n 106), we next selected 29 of the most recently
epaired non-TAR patients to form a comparison group of similar
ize operated on within our same era designation (era 3) as those
ndergoing TAR. This gave us a sample size of 56, of whom 27
nderwent TAR and 29 underwent conventional repair of multiple
SDs. In comparing outcomes between these groups, a propensity
core was created from multiple logistic regression, incorporating
ifferences in demographic, morphologic, and procedural charac-
eristics into a model that provided a probability that a given
atient belonged to one group versus another (Table E1). 
ariable was then entered into the logistic model for need for
acemaker implantation after VSD repair and linear regression
odels for the number of residual VSDs and the cumulative size
in millimeters) of the residual VSDs, to attempt to adjust for
ifferences in characteristics between the two groups. b
The Journal of Thoracicesults
ntire Patient Cohort
he patient cohort included 116 children. Median age at
ime of the operation was 9 months (range 3 days-18.1
ears). Fifty-two patients (45%) had isolated mMVSDs,
hereas 64 (55%) had associated cardiac anomalies, such as
oarctation of the aorta (n  25), transposition of the great
rteries (n  13), atrioventricular septal defect (n  8),
etralogy of Fallot (n 7), and other cardiac anomalies (n
1). Forty-six patients (40%) had previous pulmonary arte-
ial banding. The complete clinical profile of the entire
ohort is summarized in Table E2.
Early results for entire cohort. The median number of
SDs repaired was 3 (range 1-22). The mean aortic cross-
lamp time was 105  36 minutes, and the mean CPB time
as 149  52 minutes.
Significant differences between patients undergoing TAR
nd those having conventional approaches were evident. The
ean numbers of defects closed for those undergoing TAR
ersus conventional surgical repair were 6.8  3.8 and
.3  1.0, respectively (P  .001). The age at repair was
ounger in the TAR group than in those having conven-
ional repair (median 0.54 years, range 0.04-7.24 years, vs
edian 1.07 years, range 3 days-18.1 years, P .005). CPB
nd aortic crossclamp times appeared to be longer in the
AR group than in the others, but statistical significance
as not achieved.
The operative mortality was 10 of 116 (9%). The univa-
iable analysis of risk factors for operative mortality is listed
n Table 2. Multivariable logistic regression model for
rative mortality revealed the following significant indepen-
ent factors: double-outlet right ventricle (DORV, odds
atio 44.7, P  .003), ventriculotomy (odds ratio 6.4, P 
03), and smaller number of VSDs repaired (odds ratio 4.7
er VSD, P  .04; Table E3).
The incidence of complete heart block requiring place-
ent of a permanent pacemaker was 14 of 116 (12%). The
nivariable analysis of risk factors for pacemaker placement
s listed in Table 2. Multivariable logistic regression m
or pacemaker implantation revealed the following signifi-
ant risk factors: DORV (odds ratio 9.7, P  .03) and
ostoperative pulmonary arterial banding (odds ratio 6.8,
  .055; Table E3).
Late results for entire cohort. Kaplan-Meier–estimated
urvivals from repair were 93%  3% at 30 days, 90% 
% at 1 year, and 82%  5% at 7.4 years (Figure E1). C
roportional hazard regression model for time-related death
evealed the following risk factors: DORV (hazard ratio
.27, confidence interval 1.4-49.3, P .02) and longer CPB
ime (hazard ratio 1.02/min, confidence interval 1.0-1.03,
 .02).
Of importance, there was a significant interaction termetween the length of CPB and era 3, indicating that dura-
and Cardiovascular Surgery ● Volume 132, Number 5 1075
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Dion of CPB has been neutralized in the more recent era.
isk-adjusted survival stratified by era of operation (era 3 vs
thers), shown in Figure E2, demonstrates that equiva
uration of CPB time was a risk factor in earlier eras but not
ithin the most recent era (era 3; Table E3).
AR Group
he most recent 27 consecutive children underwent the
AR procedure. Fourteen had isolated mMVSDs and 13
ad associated cardiac defects, such as coarctation of the
orta (n  5), tetralogy of Fallot (n  3), atrioventricular
eptal defect (n  3), and other anomalies (n  2). Twelve
atients (44%) had more than 4 muscular defects (Swiss
heese septum) identified on preoperative echocardiogra-
hy. These defects were apical (31%), anterior (30%),
idtrabecular (24%), and posterior/inlet muscular (16%).
he patient profile is summarized in Table E4.
The median number of MVSDs closed was 7 (range
-22). Each patient had combined closure strategies as
eeded: TAR (median 5, range 2-21), patch (median 1,
ange 0-4), and device closure (range 0-1). Mean CPB and
ardiac ischemic (crossclamp) times were 146  52 and
12  38 minutes, respectively. CPB and crossclamp times
ere longer for patients with associated defects than for
hose with isolated mMVSDs (CPB 167  57 minutes vs
26  40 minutes, P  .04, and crossclamp 122  34 vs
04  40, P  .21).
One patient required intraoperative revision for residual
SD around a device. None of the patients had postopera-
ABLE 2. Univariable statistics (Fisher or2) for operative
or the entire cohort of patients with multiple muscular ve
ariable No. dead
e-endocardialization 0
ra 1 (1982-1989) 5 (5/31, 16%)
ra 2 (1990-1998) 5 (5/39, 13%)
ra 3 (1999-2005) 0
entriculotomy 3 (3/16, 19%)
trial repair 7 (7/98, 7%)
ny associated lesion 8 (8/64, 13%)
Atrioventricular septal defect 1 (1/8, 13%)
Truncus arteriosus 1 (1/2, 50%)
Coarctation of aorta 2 (2/25, 8%)
Tetralogy of Fallot 0
Double-outlet right ventricle 2 (2/4, 50%)
Transposition of great arteries 2 (2/13, 15%)
revious pulmonary arterial band 4 (4/46, 9%)
ostoperative pulmonary arterial band 1 (1/5, 20%)
ounger age at operation
onger cardiopulmonary bypass time
onger aortic crossclamp time
maller number of defects repairedive pulmonary artery banding. Ventricular function on pos- A
076 The Journal of Thoracic and Cardiovascular Surgery ● Novrepair transesophageal echocardiography was normal or
ildly reduced in 25 of 27 patients and moderately or
everely reduced in 1 patient each. The median number of
esidual VSDs by color flow Doppler was 1.5 (range 0-3),
nd the median residual jet width was 2.3 mm (range 0-4.2
m). One patient had an elevated shunt fraction of 2.1. One
atient (4%) required a permanent pacemaker for complete
eart block. Median intensive care unit stay was 3 days
range 1-16 days). There was no operative or late mortality
n the TAR group.
ropensity-adjusted Comparison
Pacemaker implantation. When pacemaker implanta-
ion was modeled with the addition of the propensity score,
ater year of operation was significant for lessened risk of
acemaker implantation (odds ratio 1.5/year since 1997,
5% CI 1.02-2.36, P  .04).
Larger postoperative VSD size (as cumulative total of
ll residual VSDs). With a linear regression, propensity-
djusted model, there was a trend toward a smaller cumu-
ative VSD size on postoperative echocardiography for the
AR group (P  .10). Other significant predictors were
urgeon (P  .03) and diagnosis of complete atrioventric-
lar septal defects (P  .04).
Number of residual VSDs. There were 32 patients who
ad 2 or more VSDs on their postoperative echocardiogram
dentified by color Doppler; 13 of these occurred in the TAR
roup, and the balance occurred in the non-TAR group.
ality (n 10/116) and pacemaker implantation (n 14/116)
ular septal defects
P value No. of pacemakers P value
.11 1 (1/27, 4%) .18
.12 6 (5/31, 16%) .52
.30 6 (6/39, 15%) .55
.006 3 (3/46, 7%) .16
.12 3 (3/16, 19%) .39
.18 11 (11/98, 11%) .46
.18 9 (9/64, 14%) .57
.53 1 (1/8, 13%) 0.001
.17 0 0.001
0.001 3 (3/25, 12%) 0.001
0.001 1 (1/7, 14%) 0.001
.04 2 (2/4, 50%) .07
.31 2 (2/13, 15%) .66
0.001 7 (7/46, 15%) .40
.37 2 (2/5, 40%) .11
.64 .55
.37 .57
.71 .24
.14 .80mort
ntricccording to univariable statistics, there was no significant
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Delationship between group and this outcome (P  .29).
ith a logistic regression, propensity score–adjusted model,
he presence of an anterior VSD compared with all other
orphologic VSD types (odds ratio 6.5, 95% confidence in-
erval 1.4-28.4, P  .01) and smaller total VSD size on
reoperative echocardiography (odds ratio 1.2/mm decrease,
5% confidence interval 1.0-1., P  .04) were significant.
iscussion
deal treatment for children with mMVSDs would be to
chieve single-stage repair, completely obliterate the VSDs,
nd avoid heart block, arrhythmias, and ventricular dysfunc-
ion. The morbidity and mortality associated with treatment
f mMVSDs remains higher than for many other diagnostic
ategories of congenital heart surgery.1-7 Several innovative
pproaches have been described, especially for those with a
wiss cheese septum. The multiplicity of management strat-
gies is evidence that an effective treatment strategy to
chieve all the ideal goals has not been reached.
The efficacy of any surgical approach to mMVSDs
hould be evaluated in terms of early operative risk, as well
s septal function and rhythm status. Our hypothesis for the
AR strategy was that complete obliteration of mMVSDs
ould be achieved, along with avoidance of atrioventricular
eart block and preservation of ventricular function, thereby
iminishing mortality. Analysis of the data yields some
nteresting findings with respect to our hypothesis.
omplete Obliteration of VSDs and Avoidance of
ostoperative Shunts
ailure to completely septate the ventricles and obliterate all
efects may result in a left-right shunt associated with the
eed for placement of a pulmonary arterial band and a high
ate of reoperation.1-6,10 From early experience in our ov-
ll cohort of patients, 3 of 6 patients who required postop-
rative pulmonary arterial banding for a residual shunt died.
ur current analysis revealed that a smaller number of
VSDs closed was an independent factor for mortality on
ultivariable analysis. In the TAR group, our strategy was
o close all exit points of interventricular communications
n the right ventricular side. We frequently discovered more
robe-detected defects than identified by preoperative echo-
ardiography. The total number of right-sided probe-patent
xit defects closed in 27 patients was 184, with a median
f 7 (range 3-22). The anterior, midtrabecular, and inlet/
osterior defects at the diaphragmatic crux were easier to
nd, whereas identification of the apical defects was the
ost challenging. The median number of residual defects in
ll 27 patients undergoing the TAR strategy was 1.5 (range
-3); most were trivial, and many were not seen by
-dimensional echocardiography (they would only be evi-
ent with color flow Doppler). The locations of residual
hunts were in the midtrabecular and apical septum in 51% t
The Journal of Thoracicnd 24% of cases, respectively. Peridevice or peripatch
eakage was seen in 14% of cases. The TAR strategy may
rove to be particularly helpful in those patients with distal
pical and anterior defects, where device application is
ifficult or impossible because of inadequate muscular rim.
lthough the exposure for apical defects may be challeng-
ng, the residual shunts have been tolerated.
reservation of Ventricular Function
urgical closure of mMVSDs is frequently complicated by
ostoperative ventricular dysfunction, thus complicating
ostoperative care of those patients and contributing to their
orbidity and mortality. Several factors may play a role in
ostoperative ventricular dysfunction and hence are avoided
n our current TAR strategy: (1) Division of the moderator
and or thick trabeculae of the right ventricular septum to
mprove exposure and identification of defects is avoide3,6
e have concerns regarding the effects of such divisions on
he function of the right ventricle, and only minor 1- to
-mm bands are occasionally divided in our practice. (2)
entriculotomy is not performed to allow access to apical
efects.2,3,8 There have been several reports of detrimen
equelae of left ventriculotomy, such as ventricular dys-
unction, local apical aneurysm formation, late arrhythmias,
nd increased operative mortality.4,8,16 Our current analysi
evealed that ventriculotomy was an independent factor for
ortality on multivariable analysis. With our TAR strategy,
e currently would not perform ventriculotomy for expo-
ure of any MVSD. If a ventriculotomy is needed for the
epair of associated cardiac lesions, such as a right ventricle
o pulmonary artery conduit, however, placement of TAR
utures can be facilitated through that incision. Moreover,
ther approaches, such as gentle probing through the inter-
trial septum and exposure of the anterior defects through
he pulmonary valve, can be used to facilitate exposure and
ntraoperative identification and closure of MVSDs. Al-
hough it has not been encountered in our series, we believe
hat exposure may be severely compromised in patients with
ysplastic tricuspid valve and a small annulus, so this tech-
ique may not be suitable in such a patient. (3) Septal
ysfunction as a result of deep suturing in the septum,
ivision of major trabeculae, or application of multiple
evices is avoided. The TAR strategy uses fine superficial
utures to approximate the trabeculae and eliminate exit
efects on the right side of the septum. Two of 27 patients
n the TAR series had moderate or severe dysfunction by
mmediate postoperative echocardiography. The patient
ith severe dysfunction had deeper sutures placed than is
ur current practice, whereas the other patient with moder-
te dysfunction had prolonged cardiac ischemic times and
2 defects closed. He had good recovery with normal biven-
ricular function on later echocardiography.
and Cardiovascular Surgery ● Volume 132, Number 5 1077
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Dvoidance of Heart Block
urgical treatment of mMVSDs is associated with high inci-
ences of septal dysfunction and complete heart block.1-7 Deep
uturing or extending the sutures into the left side of the
eptum is associated with heart block. The incidence of
omplete heart block in the literature has been disturbingly
igh, even in cases in which device or double-patch hybrid
losure techniques have been used.1-7,10 We avoid deep
uturing and approximate the adjacent trabeculae with fine
uperficial sutures. One patient in the TAR series required a
acemaker. In this patient, sutures were placed into the left
nterior septum (likely a technical issue). The low incidence
f permanent heart block in the TAR group (4%) is encour-
ging and compares favorably with the non-TAR group
15%). The relatively small sample size and the different
ariables associated with those patients may have precluded
eaningful analysis of the effect of TAR on postoperative
eart block.
iminished Operative Mortality
urgical treatment of mMVSDs has been associated with
levated mortality.1-7 The presence of mMVSDs has be
ound to be an independent risk factor for early mortality
fter repair of complex congenital heart lesions, such as
ORV or transposition of the great arteries.7,17 Similarly, we
eported in a past publication that patients with mMVSDs with
ssociated cardiac defects have an increased operative mor-
ality risk.5
In our current analysis, ventriculotomy and smaller num-
er of VSDs closed were independent factors for operative
ortality. We consequently concluded that patients with
esidual lesions such as residual shunt, ventricular dysfunc-
ion, and arrhythmias are at higher risk for increased mor-
ality. Moreover, longer CPB duration was found to be a
ignificant factor for diminished overall survival for the
ntire patient cohort. Interestingly, the effect of longer CPB
ime has been neutralized as a risk factor for death in the
urrent era. The TAR strategy, especially when associated
ith repair of additional cardiac anomalies, requires long
PB and cardiac ischemic times. Despite that, there were no
arly or late deaths in this group of patients. The cause of
iminished mortality may be multifactorial. We hypothesize
hat the adverse effects of prolonged CPB and ischemic
imes are moderated by the fact that those children have
inimal residual shunts, few arrhythmias, and little septal
nd ventricular dysfunction.
In our current practice, we recommend single-stage clo-
ure of mMVSDs at time of repair of associated cardiac
nomalies or after the development of symptoms of heart
ailure in patients with isolated defects. We rarely use
ulmonary artery banding because it is associated with
ultiple drawbacks, carries the inevitable need for reopera-ion, and may complicate subsequent repair. We would
078 The Journal of Thoracic and Cardiovascular Surgery ● Novarely reserve pulmonary artery banding for extremely ill
hildren, such as those with cerebral bleeding, infection, or
ignificant pneumonitis.
The TAR technique is a useful tool that can be applied as
eeded by surgeons, in addition to patch suturing or device
pplication, in a combined closure strategy aiming to
chieve complete obliteration of the interventricular com-
unications. It is a safe adjunct that allows preservation of
eptal function and avoidance of heart block and has a
pecial utility in Swiss cheese, apical, and anterior defects.
There are limitations of this technique. Premature infants
nd those with small tricuspid valve annuli are not good
andidates, because exposure through the tricuspid valve is
ifficult in those cases. Although our results justify pro-
onged operative time and long CPB duration as needed to
nsure complete repair and no residual pathology, patients
ho will have residual postoperative lesions that cannot be
orrected or addressed by the surgeons at the time of repair
such as those with ventricular hypertrophy or significant
ulmonary hypertension) will not tolerate prolonged isch-
mic time and extensive surgical repair.
onclusions
he outcome of surgical repair of mMVSDs (Swiss cheese
eptum) has improved. An inherent risk of mortality is
resent in patients with mMVSDs, especially those with
ssociated cardiac lesions that increase the complexity of
he physiology and the surgical repair. A strategy that ne-
ates or diminishes the residual lesions largely mitigates
isk. The technique of TAR enables complete or near com-
lete obliteration of the Swiss cheese defects with preser-
ation of the ventricular function in the vast majority of
ases. Heart block is likely a technical complication and
ay be avoidable. The risk of mMVSDs and associated
esions has been largely mitigated. Early echocardiographic
nd clinical outcomes of TAR are promising. Future follow-
p is needed to confirm the favorable results.
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iscussion
r Emile A. Bacha (Boston, Mass). Alsoufi and colleagues re-
iewed 116 patients with mMVSDs operated on through 23 years
ith various techniques at The Hospital for Sick Children. A
ubanalysis of 27 patients who underwent a new technique, TAR,
uring the last 4 years was performed. Results of the TAR group
ere very good with regard to mortality, reoperation, incidence of
eart block, and residual VSDs.
I believe that the Toronto group has developed an apparently
ew and effective way to treat some MVSDs. I emphasize some,
ecause I’m just not sure that this is the panacea we’re all looking
or.
I have two main issues with this technique. It still is a relatively
lind technique which mainly relies on probing the septum for
oles, a notoriously imprecise technique. Patients with mMVSDs
re one group for whom real-time imaging on the beating heart is
f true help in the operating room, necessitating a shift in surgical
hinking and planning.
My second concern is long-term ventricular dysfunction, which
s a big problem for these patients. There is some evidence that this
ay be due to an intrinsic myocardial problem associated with this
iagnosis. TAR has a strong trend toward longer CPB and cross-
lamp times. Adding prolonged myocardial ischemic times onto an
ntrinsically abnormal myocardium may not be the best strategy. L
The Journal of ThoracicThis brings me to the following questions. Dr Alsoufi, you
ailed to show any advantage in terms of residual VSDs between
he TAR group and the other group. How then do you justify the
onger crossclamp times associated with TAR?
The incidences of previous pulmonary arterial banding were
7% in the entire cohort and 11% in the TAR group. Have you
ompletely abandoned primary palliation with pulmonary arterial
anding, including in premature and low–birth weight babies?
Finally, when I tried a technique similar to this, I usually got
eaks from underneath other trabeculated areas that were not
losed because I couldn’t see them, especially in the apical portion
f the septum. Do you have technical points to share with us
egarding how to avoid leaks at the apex?
Dr Alsoufi. I agree that aggressive probing can create VSDs in
eonates. We carefully apply gentle probing, and we haven’t
nadvertently caused any defects in the septum so far.
Real-time imaging on a beating heart, as you suggested, is a
seful tool for intraoperative localization of isolated big MVSDs.
owever, mMVSDs are notoriously difficult to delineate on echo-
ardiography before the initial repair. The initial intraoperative
chocardiography may reveal significant jet through large defects,
owever, once major defects such as large MVSDs or perimem-
ranous VSDs are closed, additional small or moderately sized
nterior and midtrabecular defects are unmasked and detected on
ostoperative echocardiography.
It is true that those cases require long CPB and crossclamp
imes, especially those associated with other cardiac anomalies.
e have demonstrated, however, that long CPB time is no longer
n adverse factor in survival in the current era. We found that those
atients, as long as they leave the operating room without any
esidual defects and with no significant residual shunts, ventricular
ysfunction, septal dysfunction or conduction problems, are able
ithin the study limits to tolerate longer CPB time. We therefore
re encouraged to spend a longer time to achieve complete septa-
ion, as long as we know we will be able to come out with no or
inimal residual defects.
Two of the 3 bands that were done in the TAR group were from
n outside institution. We believe that pulmonary arterial banding
s not indicated for most children with mMVSDs. Pulmonary
rterial bands may complicate subsequent reoperation and identi-
cation and closure of defects because of the resultant hypertrophy
f the ventricular septum and right ventricular trabeculae. Obvi-
usly, there are problems with the bands such as distortion of the
alve and underbanding or overbanding. Moreover, patients un-
ergoing pulmonary arterial banding are subjected to inevitable
eoperation for removal of the band and closure of remaining
efects.
We have not needed to use bands in the last 4 or 5 years,
lthough I assume that the severely sick patients, such as those
ith intracranial hemorrhage or very tiny kids with significant
neumonitis, are probably candidates for pulmonary arterial band-
ng. We have not encountered such cases, however, in at least the
ast 5 years.
We have not shown any benefit in terms of the residual VSDs
o far, even though we did propensity match and it showed that the
otal size of the residual shunt to be significantly lower, with a
ignificant decrease in the number of anterior residual defects.
onger follow-up and probably larger series are needed to help us
and Cardiovascular Surgery ● Volume 132, Number 5 1079
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Demonstrate whether there is any actual significant benefit in terms
f residual defects. As you saw, many of those residual defects are
ot even evident on 2-dimensional echocardiography, they are
nly seen on color Doppler, and we’ve had no problems with 1.9
ears of echocardiographic follow-up so far.
Dr Antonio F. Corno (Liverpool, UK). I respectfully disagree
ith all that you said about the banding. And I’m fully aware that
n these meetings when we mention just “banding” it’s like going
ack to the dinosaurs’ time.
But we have a totally different policy for this group of patients
ith multiple VSDs thanks to the availability of the FloWatch, a
elemetrically controllable device. Our protocol is that we implant
he device, and then we follow up to the age of 1 year. We also
ave patients followed up to 2 years of age now. If needed, we can
elease the banding to reduce the pressure gradient with the growth
f the patient. And then these patients can undergo repair at the age
f 1 or even 2 years, when the body weight is 10 to 12 kg or more.
his approach presents several advantages. First, the technical
ifficulty when you repair multiple VSDs at 12 kg is less than at
or 4 kg, as with your patients.
Second, we have found that over 1 or 2 years of observation,
ost of the smaller defects will close, so the ischemic time
equired to close the residual defects is much shorter. And then,
hanks to the device, we never had any distortion of the pulmonary
rtery, and reconstruction of the pulmonary artery has been never
equired. I’d like your comments on this other option.
Dr Alsoufi. Obviously our and others’ past experience does not
nvolve the adjustable band, which may eliminate many of the major
roblems, such as underbanding, distortion, and overbanding.
Dr Hanley’s group, and others in the past, showed that preop-
rative banding is associated with a higher risk than primary repair.
bviously that conclusion may need to be reassessed with the
djustable bands. We don’t have those in Toronto, unfortunately.
The other important fact is that almost half of the patients will
equire early operation for the associated cardiac anomalies rather
han the VSDs. In those cases, we prefer to leave the operating
oom with no residual lesions, because the patients will do better
ostoperatively. Our indication for operation on patients with
solated mMVSDs is heart failure. Although I agree with you that
urgery is probably easier and better tolerated in an older patient,
ur experience with primary repair at an early age proves that this
s a safe treatment alternative.
Dr Carlos J. Troconis (Caracas, Venezuela). One of my major
oncerns is the transoperative identification of these multiple
SDs. To address this issue, we have been using as well as per the
pical VSDs, the cardioscope to identify those holes within the
rabeculae either directly or by instilling cold saline solution into
he left ventricular trough out an apical left ventricular vent, or
ven threading a small balloon from the left ventricular side. Do
ou think this technique will assist you in identifying the multiple
efects and allow you to be more precise and accurate in their
losure, as well as shortening the anatomic evaluation, the surgical
losure expenditure, and the crossclamp and pump times? Not
eaving residual defects or heart block with good ventricular func-
ion is the ultimate goal. d
080 The Journal of Thoracic and Cardiovascular Surgery ● NovDr Alsoufi. It’s definitely an elegant technique, and I’m sure it
as a role in some cases. In fact, Dr Black from our hospital in
oronto has reported his experience with the use of cardioscopy to
lose MVSDs in the past. We have not needed to use it in the last
ew years, because we have used the TAR technique. Maybe
ecause we’re not putting a patch, we don’t have to delineate the
xact edges of the defect; rather, we need to identify what trabe-
ulations will occlude those exit points. Nonetheless, I’m sure
ardioscopy is a useful tool that the surgeon can apply in some
ircumstances.
Dr Christo I. Tchervenkov (Montreal, Quebec, Canada). I
ould like to raise a couple of other issues. How do you count the
umber of VSDs? We all very well know that when you look at the
SD, or when you look at the left ventricular aspect of the left
entricular septum, what is a single VSD, as viewed from the right
ide, with all the crossing trabeculations, may look like 5 VSDs. It
ounds impressive to say, “I closed 9 VSDs in a patient,” when in
eality it is 1 dominant VSD and perhaps a second VSD with many
rabeculations. So that’s one issue.
The second issue, the pitfall of this technique, which is excel-
ent and it should definitely be in the armamentarium, is to perhaps
islead some surgeons to go off to really small VSDs in the
uscular septum or the apical septum that should not really be
ddressed because they’re going to close spontaneously. So how
o you decide the relative contribution of the small midmuscular
r apical MVSDs in addition to perhaps dominant perimembra-
ous or outlet VSDs? I mean, that is the real key issue.
Dr Alsoufi. The definition of Swiss cheese septum is pretty
ague. In the last Society of Thoracic Surgeons nomenclature, the
eptum was defined Swiss cheese if 4 or more VSDs existed. We
ften find that echocardiography underestimates the number of
SDs, and most of the times we find more probe patent VSDs that
e have to close.
We aim to leave the operating room with no residual shunt. I’m
ot sure we can tell whether or not the VSD that will close is going
o contribute to the patient’s status at the end. Often you close a big
erimembranous VSD, and once you relieve that big shunt, sud-
enly another small defect that you thought was not significant
ecomes significant and starts causing problems, and you have to
eoperate. Therefore our goal usually is to eliminate any interven-
ricular communication.
The other question was regarding the number of VSDs closed.
he number obviously depends on the surgical technique. So if
ou’re going to cut the trabeculations and identify the edges of the
efect and close it with a patch, you are going to end up saying that
closed 1 VSD. We don’t like to cut the trabeculations, because
hey may cause problems to the septum function, so we are
argeting the exit points on the right side. So 1 single VSD that
ould be closed with a patch may be 3 or 4 exit points requiring
AR sutures. I don’t think it matters how many VSDs you’ve
losed or you started with. What matters is your end product. We
elieve that the surgeon’s goal should be, again, no residual
efects with good function and no heart block.
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DABLE E1. Variables used to construct the propensity
core (area under the curve 0.88)
ariable P value
etralogy of Fallot .09
orphologic VSD type
Inlet .004
Midmuscular .01
Anterior .004
urgeon
A .005
B .08
ortic crossclamp time (min) .15
SD, ventricular septal defect.
TABLE E2. Clinical profile of all patients with multiple
muscular ventricular septal defects (mMVSDs)
No. of patients 116
Age range 3 d-18.1 y
Median age 9 mo
Male sex (No.) 47 (41%)
Previous pulmonary arterial band (No.) 46 (40%)
Isolated mMVSDs (No.) 52 (45%)
Associated cardiac anomalies (No.) 64 (55%)
Coarctation of the aorta 25 (22%)
Transposition of the great arteries 13 (11%)
Atrioventricular septal defect 8 (7%)
Tetralogy of Fallot 7 (6%)
Double-outlet right ventricle 4 (4%)
Persistent truncus arteriosus 2 (2%)
Other 5 (4%)
ABLE E3. Multivariable regression models for operative mortality, pacemaker implantation, and time-related survival for
16 patients with multiple muscular ventricular septal defects
ariable Parameter estimate SE OR 95% CI P value
ultivariable logistic regression model
for operative mortality
DORV 3.80 1.28 44.71 3.6-548.9 .003
Ventriculotomy 1.85 0.76 6.4 1.2-34.5 .03
Fewer VSDs repaired 1.54 0.76 4.7/per VSD 1.1-20.4 .04
ultivariable logistic regression model
for pacemaker implantation
DORV 2.28 1.05 9.7 1.2-76.5 .03
Postoperative PAB 1.87 0.97 6.8 0.96-43.4 .055
ox proportional hazard regression model
for time-related death
DORV 2.11 0.91 8.27 1.39-49.3 .02
Longer CPB time 0.02 0.007 1.02/min 1.003-1.03 .02
nteraction between CPB time and era 3*
!0.010 0.004 0.99 0.982-0.998 .04
E standard error, ; OR, Odds ratio; CI, confidence interval; DORV, double-outlet right ventricle; VSD, ventricular septal defect; PAB, pulmonary arterial
anding; CPB, cardiopulmonary bypass. *Longer bypass time has been neutral
The Journal of Thoracic anized as a risk factor for death in era 3.
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Digure E1. Kaplan-Meier estimated survival after repair of multi-
le muscular ventricular septal defects for entire cohort of 116
atients.
igure E2. Risk-adjusted predictions for time-related survival af-
er repair of multiple ventricular septal defects (VSDs) stratified
y era of operation. There was significant interaction term
hereupon similar of cardiopulmonary bypass (CPB) duration had
een neutralized in most recent era. Longer CPB time was a
isk-factor in earlier eras, but not within most recent era (Era 3).
TABLE E4. Clinical profile of patients with multiple mus-
cular ventricular septal defects (mMVSDs) undergoing
transatrial re-endocardialization
No. of patients 27
Age (range) 15 d-7.2 y
Age (median) 196 d
Weight (kg, median and range) 4.9 kg (2.4-17.6 kg)
Body surface area (median and range) 0.3 (0.17-0.66)
Male sex (No.) 7 (26%)
Isolated mMVSDs (No.) 14 (52%)
Associated cardiac anomalies (No.) 13 (48%)
Coarctation of the aorta 5 (19%)
Atrioventricular septal defect 3 (11%)
Tetralogy of Fallot 3 (11%)
Transposition of the great arteries 1 (4%)
Double-outlet right ventricle 1 (4%)080.e2 The Journal of Thoracic and Cardiovascular Surgery ● November 2006
